𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A termination mutation (2143delT) in the CFTR gene of German cystic fibrosis patients

✍ Scribed by Thilo Dörk; Nanette Kälin; Manfred Stuhrmann; Jörg Schmidtke; Burkhard Tümmler


Publisher
Springer
Year
1992
Tongue
English
Weight
710 KB
Volume
90
Category
Article
ISSN
0340-6717

No coin nor oath required. For personal study only.

✦ Synopsis


German patients with cystic fibrosis (CF) were screened for molecular lesions in exon 13 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by single strand conformation polymorphism (SSCP) and chemical cleavage of mismatch analyses. Direct sequencing of four samples that displayed the same SSCP pattern and that were susceptible to cleavage of hetero-duplexes by osmium tetroxide revealed, in all cases, a deletion of a single T residue at nucleotide position 2143 within codon 671 of the CFTR gene. As a result, leucine codon 671 is changed into a termination codon. In total, the 2143delT mutation was confirmed in 6 out of 271 German non-delta F508 CF chromosomes by artificial restriction fragment length polymorphism analysis, indicating that this frameshift mutation accounts for about 2% of German non-delta F508 mutations. The 6 pancreas insufficient patients who are compound heterozygous for 2143-delT suffer from the typical features of pulmonary and gastrointestinal CF disease. The 2143delT mutation completes the panel of the more frequent CFTR mutations that reside on the "delta F508 haplotype" and that contribute to its overpresentation among German non-delta F508 alleles that are associated with severe forms of disease.


📜 SIMILAR VOLUMES


The spectrum of CFTR mutations in south-
✍ M. Lindner; A. Wolf; B. Moh; P. Steinbach; E. Kleihauer; C. R. Bartram; A. E. Ku 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 298 KB

The cystic fibrosis transmembrane conductance regulator (CFTR) gene of 110 cystic fibrosis (CF) patients from the south-west of Germany was screened for 12 different mutations. This analysis resulted in an identification of 79% of all CF mutations and a complete genotype in 66% of the families. The

Incidence and expression of the N1303K m
✍ L. Osborne; G. Santis; M. Schwarz; K. Klinger; T. Dörk; I. McIntosh; M. Schwartz 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 590 KB

The N1303K mutation was identified in the second nucleotide binding fold of the cystic fibrosis (CF) gene last year. We have gathered data from laboratories throughout Europe and the United States of America in order to estimate its frequency and to attempt to characterise the clinical manifestation

Heterogeneity in the severity of cystic
✍ Michael Dean; George Santis 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 589 KB

Cystic fibrosis is a common, fatal disorder caused by abnormalities in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. CFTR encodes a chloride channel that regulates secretion in many exocrine tissues. The presentation of cystic fibrosis is highly variable as measured by the age